U.S. market Closed. Opens in 10 hours 47 minutes

INMD | InMode Ltd. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 17.02 - 17.30
52 Week Range 14.87 - 26.80
Beta 2.45
Implied Volatility 48.45%
IV Rank 43.36%
Day's Volume 695,554
Average Volume 1,019,214
Shares Outstanding 84,619,100
Market Cap 1,448,678,992
Sector Healthcare
Industry Medical - Devices
IPO Date 2019-08-08
Valuation
Profitability
Growth
Health
P/E Ratio 9.36
Forward P/E Ratio 14.96
EPS 1.83
1YR Price Target 55.00
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 581
Country Israel
Website INMD
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.
INMD's peers: ALGN, BFLY, DXCM, TMDX, INSP, NARI, PODD, EW, SWAV, SYK, BSX, ABT, MDT, ZBH, TNDM, MASS, NVCR, PEN, SENS
*Chart delayed
Analyzing fundamentals for INMD we got that it has strong fundamentals where Valuation is considered to be significantly undervalued, Profitability is stunning wealthy, Growth is exceptionally good and Health is strong. For more detailed analysis please see INMD Fundamentals page.

Watching at INMD technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INMD Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙